- Home
- MITT vs SGHT Comparison
MITT vs SGHT Comparison
Compare MITT & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITT
- SGHT
- Stock Information
- Founded
- MITT 2011
- SGHT 2011
- Country
- MITT United States
- SGHT United States
- Employees
- MITT N/A
- SGHT N/A
- Industry
- MITT Real Estate Investment Trusts
- SGHT Medical Specialities
- Sector
- MITT Real Estate
- SGHT Health Care
- Exchange
- MITT Nasdaq
- SGHT Nasdaq
- Market Cap
- MITT 230.0M
- SGHT 193.2M
- IPO Year
- MITT 2011
- SGHT 2021
- Fundamental
- Price
- MITT $7.76
- SGHT $3.42
- Analyst Decision
- MITT Strong Buy
- SGHT Buy
- Analyst Count
- MITT 5
- SGHT 8
- Target Price
- MITT $8.50
- SGHT $4.29
- AVG Volume (30 Days)
- MITT 146.3K
- SGHT 105.8K
- Earning Date
- MITT 11-04-2025
- SGHT 11-06-2025
- Dividend Yield
- MITT 10.73%
- SGHT N/A
- EPS Growth
- MITT N/A
- SGHT N/A
- EPS
- MITT 0.86
- SGHT N/A
- Revenue
- MITT $83,509,000.00
- SGHT $76,303,000.00
- Revenue This Year
- MITT N/A
- SGHT N/A
- Revenue Next Year
- MITT $13.95
- SGHT $12.04
- P/E Ratio
- MITT $9.12
- SGHT N/A
- Revenue Growth
- MITT 25.02
- SGHT N/A
- 52 Week Low
- MITT $5.63
- SGHT $2.03
- 52 Week High
- MITT $7.95
- SGHT $7.03
- Technical
- Relative Strength Index (RSI)
- MITT 55.98
- SGHT 36.78
- Support Level
- MITT $7.62
- SGHT $3.38
- Resistance Level
- MITT $7.88
- SGHT $3.65
- Average True Range (ATR)
- MITT 0.13
- SGHT 0.18
- MACD
- MITT 0.01
- SGHT -0.06
- Stochastic Oscillator
- MITT 62.06
- SGHT 5.26
About MITT AG Mortgage Investment Trust Inc.
AG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. It also focuses on investing in residential mortgage-backed securities (RMBS) issued or guaranteed by a government-sponsored enterprise.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.